Kristie Banks

Kristie Banks is an accomplished executive with extensive experience in the biotechnology and technology sectors. Currently serving as Vice President at Gilead Sciences since October 2008, Kristie leads the U.S. Managed Markets and the COVID-19 Business Unit, overseeing sales and marketing for the COVID-19 product Veklury. Prior roles at Gilead include Vice President of Managed Markets Strategy & Operations and Senior Director of Business Operations & Contract Compliance. Kristie also holds experience as a Board Member and Commercial Lead at Asegua Therapeutics, and previously worked in customer relations roles at Rakuten.com and Oracle Corporation. Kristie earned a Bachelor of Science degree in Business Administration from Sonoma State University.